| AbbVie AG - Ozurdex, intravitreales Implantat in Applikator |
| 60324 | | 01 | | Ozurdex | | intravitreales Implantat in Applikator | | S01BA01 | | Dexamethason | | 10.01.2011 | | |
|
| Composition |
| dexamethasonum 700 µg, poly(lactidum-co-glycolidum) 50/50 (0.16 - 0.24 dl/g) terminatum cum esteri, poly(lactidum-co-glycolidum) 50/50 (0.16 - 0.24 dl/g), hypromellosum, pro praeparatione. |
| Packungsbestandteile |
| intravitreales Implantat in Applikator | | | | | | | | Principe actif | Concentr. |
|---|
| Dexamethasone | 700 µg |
| | BAG: Principe actif | Concentr. |
|---|
| Dexamethasone | 0.7 mg |
| | | | Agents auxilliaires |
|---|
| Hypromellosum | | Poly(Lactidum-Co-Glycolidum) 50/50 (0.16-0.24 Dl/g) | | Poly(Lactidum-Co-Glycolidum) 50/50 (0.16-0.24 Dl/g) Terminatum cum Esteri |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | pièce(s) | 951.69 | 1051.45 | A | LS | Non |
|
